Mechanisms underlying basal and learning-related intrinsic excitability in a mouse model of Alzheimer's disease

Neurobiology of Aging

Volumn 32, Issue 8, 2011, Pages 1452-1465

  Kaczorowski, C C ^a,b   Sametsky, E ^b   Shah, S ^b   Vassar, R ^b   Disterhoft, J F ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

AD; Afterhyperpolarization; Aging; AHP; Alzheimer's disease; CA1; Fear conditioning; Hippocampus; Intrinsic excitability; Intrinsic plasticity; Trace fear conditioning

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; CALCIUM ION; PRESENILIN 1;

AFTERHYPERPOLARIZATION; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APP GENE; ARTICLE; CHOLINERGIC ACTIVITY; CONDITIONING; CONTROLLED STUDY; DISEASE MODEL; FEAR; GENE; GENE MUTATION; INTRACELLULAR RECORDING; LEARNING; MALE; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PS1 GENE; WHOLE CELL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CALCIUM; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; HUMANS; LEARNING; MALE; MICE; MICE, TRANSGENIC; ORGAN CULTURE TECHNIQUES; PRESENILIN-1;

EID: 79959581845     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.09.003     Document Type: Article

References (85)

1. Arispe N., Pollard H.B., Rojas E. Beta-amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease. Mol. Cell. Biochem. 1994, 140(2):119-125.
2. Barrow P.A., Empson R.M., Gladwell S.J., Anderson C.M., Killick R., Yu X., Jefferys J.G., Duff K. Functional phenotype in transgenic mice expressing mutant human presenilin-1. Neurobiol. Dis. 2000, 7(2):119-126.
3. Bhatia R., Lin H., Lal R. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. FASEB J. 2000, 14(9):1233-1243.
4. Caccamo A., Oddo S., Billings L.M., Green K.N., Martinez-Coria H., Fisher A., LaFerla F.M. M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 2006, 49(5):671-682.
5. Chang E.H., Savage M.J., Flood D.G., Thomas J.M., Levy R.B., Mahadomrongkul V., Shirao T., Aoki C., Huerta P.T. AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(9):3410-3415.
6. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., Justice A., McConlogue L., Games D., Freedman S.B., Morris R.G. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 2000, 408(6815):975-979.
7. Chowdhury N., Quinn J.J., Fanselow M.S. Dorsal hippocampus involvement in trace fear conditioning with long, but not short, trace intervals in mice. Behav. Neurosci. 2005, 119(5):1396-1402.
8. Craft J.M., Van Eldik L.J., Zasadzki M., Hu W., Watterson D.M. Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human beta-amyloid in a murine model of neuroinflammation. J. Mol. Neurosci. 2004, 24(1):115-122.
9. Disterhoft J.F., Oh M.M. Pharmacological and molecular enhancement of learning in aging and Alzheimer's disease. J. Physiol. Paris 2006, 99(2-3):180-192.
10. Dodart J.C., Bales K.R., Gannon K.S., Greene S.J., DeMattos R.B., Mathis C., DeLong C.A., Wu S., Wu X., Holtzman D.M., Paul S.M. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat. Neurosci. 2002, 5(5):452-457.
11. Duff K., Eckman C., Zehr C., Yu X., Prada C.M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 1996, 383(6602):710-713.
12. Fitzjohn S.M., Morton R.A., Kuenzi F., Rosahl T.W., Shearman M., Lewis H., Smith D., Reynolds D.S., Davies C.H., Collingridge G.L., Seabrook G.R. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. J. Neurosci. 2001, 21(13):4691-4698.
13. Golding N.L., Kath W.L., Spruston N. Dichotomy of action-potential backpropagation in CA1 pyramidal neuron dendrites. J. Neurophysiol. 2001, 86(6):2998-3010.
14. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., Krafft G.A., Klein W.L. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. U.S.A. 2003, 100(18):10417-10422.
15. Goodman Y., Mattson M.P. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp. Neurol. 1994, 128(1):1-12.
16. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297(5580):353-356.
17. Hartley D.M., Walsh D.M., Ye C.P., Diehl T., Vasquez S., Vassilev P.M., Teplow D.B., Selkoe D.J. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 1999, 19(20):8876-8884.
18. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav. Genet. 1999, 29(3):177-185.
19. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. U.S.A. 1999, 96(6):3228-3233.
20. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996, 274(5284):99-102.
21. Hutton M., Perez-Tur J., Hardy J. Genetics of Alzheimer's disease. Essays Biochem. 1998, 33:117-131.
22. Jacobsen J.S., Wu C.C., Redwine J.M., Comery T.A., Arias R., Bowlby M., Martone R., Morrison J.H., Pangalos M.N., Reinhart P.H., Bloom F.E. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(13):5161-5166.
23. Kaczorowski, C.C., 2006. Intrinsic plasticity in CA1 pyramidal neurons: role of calcium(2+)- and sodium(+)-activated potassium currents in aging and Alzheimer's disease. Dissertation, 1-291.
24. Kaczorowski C.C., Disterhoft J.F. Memory deficits are associated with impaired ability to modulate neuronal excitability in middle-aged mice. Learn. Mem. 2009, 16(6):362-366.
25. Kaczorowski C.C., Disterhoft J., Spruston N. Stability and plasticity of intrinsic membrane properties in hippocampal CA1 pyramidal neurons: effects of internal anions. J. Physiol. 2007, 578(Pt 3):799-818.
26. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., Malinow R. APP processing and synaptic function. Neuron 2003, 37(6):925-937.
27. Kawahara M., Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res. Bull. 2000, 53(4):389-397.
28. Khachaturian Z.S. Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neurobiol. Aging 1987, 8(4):345-346.
29. Koistinaho M., Ort M., Cimadevilla J.M., Vondrous R., Cordell B., Koistinaho J., Bures J., Higgins L.S. Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(25):14675-14680.
30. Kramar E.A., Lin B., Lin C.Y., Arai A.C., Gall C.M., Lynch G. A novel mechanism for the facilitation of theta-induced long-term potentiation by brain-derived neurotrophic factor. J. Neurosci. 2004, 24(22):5151-5161.
31. Kronforst-Collins M.A., Moriearty P.L., Ralph M., Becker R.E., Schmidt B., Thompson L.T., Disterhoft J.F. Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits. Pharmacol. Biochem. Behav. 1997, 56(1):103-110.
32. Kronforst-Collins M.A., Moriearty P.L., Schmidt B., Disterhoft J.F. Metrifonate improves associative learning and retention in aging rabbits. Behav. Neurosci. 1997, 111(5):1031-1040.
33. Kumar A., Foster T.C. Enhanced long-term potentiation during aging is masked by processes involving intracellular calcium stores. J. Neurophysiol. 2004, 91(6):2437-2444.
34. Kuo, A.G., Lee, G., Disterhoft, J.F., 2004. Alteration of sIAHP underlies reduction of AHP in rat CA1 pyramidal neurons after trace eyebink conditioning. Soc. Neurosci. Abst. 741.13.
35. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 2002, 3(11):862-872.
36. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(11):6448-6453.
37. Lancaster B., Nicoll R.A. Properties of two calcium-activated hyperpolarizations in rat hippocampal neurones. J. Physiol. 1987, 389:187-203.
38. Lancaster B., Hu H., Ramakers G.M., Storm J.F. Interaction between synaptic excitation and slow afterhyperpolarization current in rat hippocampal pyramidal cells. J. Physiol. 2001, 536(Pt 3):809-823.
39. Landfield P.W., Pitler T.A. Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats. Science 1984, 226(4678):1089-1092.
40. Le Ray D., Fernandez De Sevilla D., Belen Porto A., Fuenzalida M., Buno W. Heterosynaptic metaplastic regulation of synaptic efficacy in CA1 pyramidal neurons of rat hippocampus. Hippocampus 2004, 14(8):1011-1025.
41. Madison D.V., Nicoll R.A. Control of the repetitive discharge of rat CA 1 pyramidal neurones in vitro. J. Physiol. 1984, 354:319-331.
42. Matthews E., Linardakis J.M., Disterhoft J.F. The fast AHP and the slow AHP are differentially modulated in hippocampal neurons by aging and by learning. J. Neurosci. 2009, 29(15):4750-4755.
43. Mattson M.P., Chan S.L. Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 2003, 34(4-5):385-397.
44. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 1992, 12(2):376-389.
45. Mattson M.P., Tomaselli K.J., Rydel R.E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res. 1993, 621(1):35-49.
46. McKay, B.M., Matthews, E.A., Oliveira, F.A., Disterhoft, J.F. Intrinsic neuronal excitability is reversibly altered by a single experience in fear conditioning. J. Neurophysiol., in press.
47. Metz A.E., Jarsky T., Martina M., Spruston N. R-type calcium channels contribute to afterdepolarization and bursting in hippocampal CA1 pyramidal neurons. J. Neurosci. 2005, 25(24):5763-5773.
48. Moyer J.R., Brown T.H. Impaired trace and contextual fear conditioning in aged rats. Behav. Neurosci. 2006, 120(3):612-624.
49. Moyer J.R., Thompson L.T., Black J.P., Disterhoft J.F. Nimodipine increases excitability of rabbit CA1 pyramidal neurons in an age- and concentration-dependent manner. J. Neurophysiol. 1992, 68(6):2100-2109.
50. Moyer J.R., Power J.M., Thompson L.T., Disterhoft J.F. Increased excitability of aged rabbit CA1 neurons after trace eyeblink conditioning. J. Neurosci. 2000, 20(14):5476-5482.
51. Murphy G.G., Fedorov N.B., Giese K.P., Ohno M., Friedman E., Chen R., Silva A.J. Increased neuronal excitability, synaptic plasticity, and learning in aged Kvbeta1.1 knockout mice. Curr. Biol. 2004, 14(21):1907-1915.
52. Nalbantoglu J., Tirado-Santiago G., Lahsaini A., Poirier J., Goncalves O., Verge G., Momoli F., Welner S.A., Massicotte G., Julien J.P., Shapiro M.L. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 1997, 387(6632):500-505.
53. Neary D., Snowden J.S., Mann D.M., Bowen D.M., Sims N.R., Northen B., Yates P.O., Davison A.N. Alzheimer's disease: a correlative study. J. Neurol. Neurosurg. Psychiatry 1986, 49(3):229-237.
54. Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., Vassar R. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 2006, 26(40):10129-10140.
55. Oh M.M., Power J.M., Thompson L.T., Moriearty P.L., Disterhoft J.F. Metrifonate increases neuronal excitability in CA1 pyramidal neurons from both young and aging rabbit hippocampus. J. Neurosci. 1999, 19(5):1814-1823.
56. Oh M.M., Kuo A.G., Wu W.W., Sametsky E.A., Disterhoft J.F. Watermaze learning enhances excitability of CA1 pyramidal neurons. J. Neurophysiol. 2003, 90(4):2171-2179.
57. Ohno M., Sametsky E.A., Younkin L.H., Oakley H., Younkin S.G., Citron M., Vassar R., Disterhoft J.F. BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 2004, 41(1):27-33.
58. Ohno M., Chang L., Tseng W., Oakley H., Citron M., Klein W.L., Vassar R., Disterhoft J.F. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Eur. J. Neurosci. 2006, 23(1):251-260.
59. Ohno M., Sametsky E.A., Silva A.J., Disterhoft J.F. Differential effects of alphaCaMKII mutation on hippocampal learning and changes in intrinsic neuronal excitability. Eur. J. Neurosci. 2006, 23(8):2235-2240.
60. Pitler T.A., Landfield P.W. Aging-related prolongation of calcium spike duration in rat hippocampal slice neurons. Brain Res. 1990, 508(1):1-6.
61. Power J.M., Oh M.M., Disterhoft J.F. Metrifonate decreases sI(AHP) in CA1 pyramidal neurons in vitro. J. Neurophysiol. 2001, 85(1):319-322.
62. Power J.M., Wu W.W., Sametsky E., Oh M.M., Disterhoft J.F. Age-related enhancement of the slow outward calcium-activated potassium current in hippocampal CA1 pyramidal neurons in vitro. J. Neurosci. 2002, 22(16):7234-7243.
63. Saar D., Grossman Y., Barkai E. Long-lasting cholinergic modulation underlies rule learning in rats. J. Neurosci. 2001, 21(4):1385-1392.
64. Sah P. Ca(2+)-activated K+ currents in neurones: types, physiological roles and modulation. Trends Neurosci. 1996, 19(4):150-154.
65. Saito K., Elce J.S., Hamos J.E., Nixon R.A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 1993, 90(7):2628-2632.
66. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 1996, 2(8):864-870.
67. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81(2):741-766.
68. Selkoe D.J., Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 2003, 43:545-584.
69. Sisodia S.S. Alzheimer's disease: perspectives for the new millennium. J. Clin. Invest. 1999, 104(9):1169-1170.
70. Sourdet V., Russier M., Daoudal G., Ankri N., Debanne D. Long-term enhancement of neuronal excitability and temporal fidelity mediated by metabotropic glutamate receptor subtype 5. J. Neurosci. 2003, 23(32):10238-10248.
71. Storm J.F. Potassium currents in hippocampal pyramidal cells. Prog. Brain Res. 1990, 83:161-187.
72. Stutzmann G.E., Smith I., Caccamo A., Oddo S., Laferla F.M., Parker I. Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice. J. Neurosci. 2006, 26(19):5180-5189.
73. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30(4):572-580.
74. Thibault O., Hadley R., Landfield P.W. Elevated postsynaptic [Ca2+]i and L-type calcium channel activity in aged hippocampal neurons: relationship to impaired synaptic plasticity. J. Neurosci. 2001, 21(24):9744-9756.
75. Thibault O., Gant J.C., Landfield P.W. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 2007, 6(3):307-317.
76. Tombaugh G.C., Rowe W.B., Rose G.M. The slow afterhyperpolarization in hippocampal CA1 neurons covaries with spatial learning ability in aged Fisher 344 rats. J. Neurosci. 2005, 25(10):2609-2616.
77. Tseng B.P., Kitazawa M., LaFerla F.M. Amyloid beta-peptide: the inside story. Curr. Alzheimer Res. 2004, 1(4):231-239.
78. Turner P.R., O'Connor K., Tate W.P., Abraham W.C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 2003, 70(1):1-32.
79. Vassar R. BACE1: the beta-secretase enzyme in Alzheimer's disease. J. Mol. Neurosci. 2004, 23(1-2):105-114.
80. Weiss C., Preston A.R., Oh M.M., Schwarz R.D., Welty D., Disterhoft J.F. The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons. J. Neurosci. 2000, 20(2):783-790.
81. Xie C.W. Calcium-regulated signaling pathways: role in amyloid beta-induced synaptic dysfunction. Neuromol. Med. 2004, 6(1):53-64.
82. Younkin S.G. The amyloid beta protein precursor mutations linked to familial Alzheimer's disease alter processing in a way that fosters amyloid deposition. Tohoku J. Exp. Med. 1994, 174(3):217-223.
83. Younkin S.G. The role of A beta 42 in Alzheimer's disease. J. Physiol. Paris 1998, 92(3-4):289-292.
84. Yun S.H., Gamkrelidze G., Stine W.B., Sullivan P.M., Pasternak J.F., Ladu M.J., Trommer B.L. Amyloid-beta(1-42) reduces neuronal excitability in mouse dentate gyrus. Neurosci. Lett. 2006, 403(1-2):162-165.
85. Zhang W., Linden D.J. The other side of the engram: experience-driven changes in neuronal intrinsic excitability. Nat. Rev. Neurosci. 2003, 4(11):885-900.